No abstract available
Keywords:
Contrast enhancement; Myelopathy; Nitrous oxide abuse.
PubMed Disclaimer
Conflict of interest statement
References
-
-
Layzer R.B., Fishman R.A., Schafer J.A. Neuropathy following abuse of nitrous oxide. Neurology. 1978;28(5):504. doi: 10.1212/WNL.28.5.504.
-
DOI
-
PubMed
-
-
Anses . 2021. Protoxyde d’azote. Bilan des cas rapportés aux Centres antipoison en 2020 (saisine 2021-AST-0027)
-
-
Vollhardt R., Mazoyer J., Bernardaud L., et al. Neurological consequences of recreational nitrous oxide abuse during SARS-CoV-2 pandemic. J. Neurol. 2021 doi: 10.1007/s00415-021-10748-7. Published online August 21.
-
DOI
-
PMC
-
PubMed
-
-
Pema P.J., Horak H.A., Wyatt R.H. Myelopathy caused by nitrous oxide toxicity. Am. J. Neuroradiol. 1998;19(5):894–896.
-
PMC
-
PubMed
-
-
Bao L., Li Q., Li Q., et al. Clinical, electrophysiological and radiological features of nitrous oxide-induced neurological disorders. NDT. 2020;16:977–984. doi: 10.2147/NDT.S236939.
-
DOI
-
PMC
-
PubMed